65 related articles for article (PubMed ID: 1704464)
21. [Study on nitroblue tetrazolium (NBT) reduction by neutrophils. II. Clinicopathological evaluation of NBT reduction test (author's transl)].
Tomonaga M
Rinsho Ketsueki; 1980 Mar; 21(3):363-74. PubMed ID: 7411876
[No Abstract] [Full Text] [Related]
22. [The prognostic assessment of patient survival in chronic myeloleukemia].
Petukhov VI; Bondar' DK; Rastrigin VL
Ter Arkh; 1991; 63(12):73-7. PubMed ID: 1803608
[TBL] [Abstract][Full Text] [Related]
23. [Thymidine kinase activity in leukocytes from patients with chronic myeloid leukemia at various periods in the disease].
Filanovskaia LI; Togo AV; Shcherbakova EG; Blinov MN
Vopr Med Khim; 1994; 40(1):29-32. PubMed ID: 8122406
[TBL] [Abstract][Full Text] [Related]
24. [The response of neutrophils to endotoxin stimulation using the NBT test in cord blood of newborn infants].
Sariaslan M; Ulukutlu L; Bilger M; Tözüm R; Hizal S
Pediatrie; 1981 Jun; 36(4):271-6. PubMed ID: 7290846
[No Abstract] [Full Text] [Related]
25. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
26. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
[TBL] [Abstract][Full Text] [Related]
27. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
28. No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia.
Deininger M; Lehmann T; Krahl R; Hennig E; Müller C; Niederwieser D
Blood; 2000 Jul; 96(2):779-80. PubMed ID: 10950517
[No Abstract] [Full Text] [Related]
29. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
Chai SK; Nichols GL; Rothman P
J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker.
Sun X; Li J; Chen J; Li D; Chen L; Xu W; Yang Y; Wu Y; Jiang P; Xie W
Ann Hematol; 2009 Jan; 88(1):29-36. PubMed ID: 18696070
[TBL] [Abstract][Full Text] [Related]
31. [The thrombocytic beta-thromboglobulin level of patients with blastic leukemia and chronic myeloleukemia].
Genova V; Kurtev I
Vutr Boles; 1988; 27(4):54-7. PubMed ID: 2975086
[TBL] [Abstract][Full Text] [Related]
32. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
Hur M; Song EY; Kang SH; Shin DH; Kim JY; Park SS; Cho HI
Ann Hematol; 2002 Apr; 81(4):219-23. PubMed ID: 11976825
[TBL] [Abstract][Full Text] [Related]
33. [Use of the NBT test for evaluating the sensitivity of neutrophils to stimulants].
Shcherbakov VI
Lab Delo; 1989; (1):30-3. PubMed ID: 2468021
[TBL] [Abstract][Full Text] [Related]
34. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
Schultheis B; Pasternak G; Hehlmann R
Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
[TBL] [Abstract][Full Text] [Related]
35. [Effect of treatment on the indicators of the spontaneous nitroblue tetrazolium reduction test in chronic nonspecific bronchopulmonary diseases].
Bernacka K; Nowicki J
Wiad Lek; 1981 Feb; 34(4):265-71. PubMed ID: 7257400
[No Abstract] [Full Text] [Related]
36. [Functional activity of the blood polymorphonuclear leukocytes in vascular lesions of the brain].
Klebanov GI; Gusev EI; Kuznetsov SV; Nifontova LA; Kreĭnina MV
Klin Med (Mosk); 1988 Sep; 66(9):82-5. PubMed ID: 3204969
[No Abstract] [Full Text] [Related]
37. Lineage involvement in chronic myeloid leukaemia: comparison between MBCR/ABL and mBCR/ABL cases.
Primo D; Sanchez ML; Espinosa AB; Tabernero MD; Rasillo A; Sayagués JM; Gonzalez M; Hernandez JM; Orfao A
Br J Haematol; 2006 Mar; 132(6):736-9. PubMed ID: 16487173
[TBL] [Abstract][Full Text] [Related]
38. [Changes in the content of bound polyamines in the whole blood in patients with chronic leukemia].
Voronchikhina LD; Dem'ianova VT; Berdinskikh NK; Kolupaeva NV
Vrach Delo; 1988 Sep; (9):64-6. PubMed ID: 3213003
[No Abstract] [Full Text] [Related]
39. [Spurious hypoglycemia and chronic myeloid leukemia].
de Sas M; Fernández G; Novoa F
Med Clin (Barc); 1991 Mar; 96(9):356. PubMed ID: 2046447
[No Abstract] [Full Text] [Related]
40. Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR).
Udomsakdi-Auewarakul C; U-Pratya Y; Boonmoh S; Vatanavicharn S
J Med Assoc Thai; 2000 Aug; 83(8):928-35. PubMed ID: 10998848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
